| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.0045 | 1 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |